Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Life Sciences
Efficacy And Safety Of Everolimus-Exemestane Combination In Breast Cancer Patients, Siba Jneid, S. Hlais, George Chahine, Doua Issa, Thouraya Domyati
Efficacy And Safety Of Everolimus-Exemestane Combination In Breast Cancer Patients, Siba Jneid, S. Hlais, George Chahine, Doua Issa, Thouraya Domyati
BAU Journal - Health and Wellbeing
Breast cancer is the second leading cause of cancer death in women worldwide. In Lebanon, hormone positive patients resistant to endocrine treatments account for most of the cases. These two facts directed the attention to evaluate everolimus-exemestane use in hormonal receptor positive metastatic breast cancer patients, in Lebanon. A multi-center, observational, retrospective cohort study was carried out by screening 69 metastatic breast cancer patient’s files in order to determine the progression free survival (PFS), overall survival (OS) and side effects of everolimus. This study revealed that across different therapy lines, the median PFS for patients on everolimus-exemestane combination was 5.87 …